Cutaneous signs of acromegaly

International Journal of Dermatology

Volumn 41, Issue 10, 2002, Pages 631-634

  Centurión, Santiago A ^a   Schwartz, Robert A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ANGIOPEPTIN; BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; GLUCOSE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; LONG ACTING DRUG; MESSENGER RNA; OCTREOTIDE; PROTEIN G; RETINOIC ACID; SOMATOMEDIN C; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE;

ACANTHOSIS NIGRICANS; ACROMEGALY; CLINICAL FEATURE; CONFERENCE PAPER; CORRELATION ANALYSIS; CREAM; DISEASE MARKER; DRUG EFFECT; EYELID DISEASE; GIGANTISM; GROWTH HORMONE RELEASE; HEADACHE; HEMIANOPIA; HEREDITY; HETEROZYGOSITY; HISTOLOGY; HUMAN; HYPERHIDROSIS; HYPERPROLACTINEMIA; HYPERTRICHOSIS; HYPOPHYSECTOMY; HYPOPHYSIS TUMOR; HYPOTHALAMUS FUNCTION; IMMUNOREACTIVITY; MORBIDITY; MORTALITY; NAIL DISEASE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; SEBORRHEA; SKIN DISEASE; SKIN EDEMA; SURGICAL TECHNIQUE; VISUAL FIELD DEFECT;

ACROMEGALY; HUMANS; SKIN DISEASES;

EID: 0036774784     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2002.01638.x     Document Type: Conference Paper

References (16)

1. Daughaday WH. Pituitary gigantism. Endocrinol Metab Clin North Am 1992; 21: 633-647.
2. Nabarro ID. Acromegaly. Clin Endocrinol 1987; 26; 481-512.
3. Gadelha MR, Rhode K, Kineman RD, Frohman LA. Isolated familial somatotropinomas: establishment of linkage to chromosome 11q13.1-11q13.3 and evidence for a potential second locus at chromosome 2p16-12. J Clin Endocrinol Metab 2000; 85: 707-717.
4. Tinschert S, Geri H, Gewies A, et al. McCune-Albright syndrome: clinical and molecular evidence of mosaicism in an unusual giant patient. Am J Med Genet 1999; 83: 100-108.
5. Watson IC, Stratakis CA, Bryant-Greenwood PK, et al. Neurosurgical implications of Carney complex. J Neurosurg 2000; 92: 413-418.
6. Naritomi K. Megalencephaly with gigantism, cerebral gigantism (Sotos syndrome). Ryoikibetsu Shokogun Shirizu 2000; 3: 533-536.
7. Eugster EA, Pescovitz OH. Gigantism. J Clin Endocrinol Metab 1999; 84: 4379-4384.
8. Cohen MM Jr. Overgrowth syndromes: an update. Adv Pediatr 1999; 46: 441-491.
9. Alavi S,Chakrapani A, Kher A, Bharucha BA. The Proteus syndrome. I. Postgrad Med 1999; 39: 219-221.
10. Lobie PE, Breipohl W,Lincoln DT. Localization of the growth hormone receptor/binding protein in skin. J Endocrinol 1990; 126: 467-471.
11. Philpott MP, Sanders DA, Kealey T. Effects of insulin and insulin-like growth factors on cultured human hair follicles: IGF-I at physiologic concentrations is an important regulator of hair follicle growth in vitro. J Invest Dermatol 1994; 102: 857-861.
12. Kovacs K. Pathology of growth hormone excess. Pathol Res Pract 1988; 183: 565-568.
13. Olney AH. Overgrowth syndromes. Pediatr Ann 1990; 19: 129-137.
14. Sotos IF. Overgrowth hormonal causes. Clin Pediatr 1996; 35: 579-590.
15. Sotos IF. Overgrowth. Section VI. Genetic syndromes and other disorders associated with overgrowth. Clin Pediatr 1997; 36: 157-170.
16. Sotos IF. Overgrowth. Section V. Syndromes and other disorders associated with overgrowth. Clin Pediatr 1997; 36: 89-103.